Protara Therapeutics (TARA) Income Statement: Revenue & Earnings

Protara Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Protara Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	31.70	24.99	16.81	21.09	11.98
Selling, General & Administrative	17.45	18.62	20.74	26.40	22.46
Operating Expenses	49.15	43.61	37.55	47.49	34.44
Operating Income	-49.15	-43.61	-37.55	-47.49	-34.44
Other Income/Expense
Interest Income	4.14	3.18	2.23	1.97	0.50
Interest Expense	0.00	0.00	1.14	1.74	-0.03
Other Income/Expense	0.42	-3.16	-29.50	1.50	-0.50
Income
Income Before Tax	-44.60	-40.42	-65.95	-47.25	-33.98
Income Tax Expense	0.00	-13.75	-9.02	-8.92	-8.65
Net Income	-44.60	-40.42	-65.95	-47.25	-33.98
Net Income - Continuous Operations	-44.60	-40.42	-65.95	-47.25	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-48.82	-53.26	-64.57	-45.40	-34.34
EBIT	-49.15	-54.17	-64.82	-45.52	-34.44
Depreciation & Amortization	0.33	0.34	0.25	0.12	0.10
Earnings Per Share
Basic EPS	-2.00	-4.00	-6.00	-4.00	-5.00
Diluted EPS	-2.00	-4.00	-6.00	-4.00	-5.00
Basic Shares Outstanding	20.59	11.33	11.26	11.23	7.23
Diluted Shares Outstanding	20.59	11.33	11.26	11.23	7.23